Rapid developments in innovative urinary incontinence devices and increase in urological disorders among the geriatric population drive the growth of the global urinary incontinence devices market. However, lack of awareness about the benefits of urinary incontinence devices and post-operative complications associated with such devices hamper the market growth. On the other hand, growing healthcare expenditures in developing countries are expected to create lucrative opportunities in future.
The global Urinary Incontinence Device Market generated $2.09 billion in 2020, and is estimated to reach $6.17 billion by 2030, witnessing a CAGR of 11.8% from 2021 to 2030.
For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/4550
Covid-19 Scenario:
- Outpatient clinics for female urinary incontinence, infertility and sexual medicine, benign prostatic hyperplasia, renal stone, benign scrotal conditions, and bladder stone were affected significantly.
- In 2020, there was a considerable reduction in different types of outpatient tests and surgical treatments for female urinary incontinence, kidney stones, infertility, and bladder stones. These treatments had the greatest rates of cut-down services. In addition, many market players underwent a revenue drop in the urology platform.
The report offers detailed segmentation of the global urinary incontinence device market based on product, category, incontinence type, end user, and region.
Development of innovative urinary incontinence devices and rise in demand for minimally invasive procedures, increase in aging population coupled with high risk of urological disorders, and rise in shift from conventional solutions to novel urinary incontinent products are some factors which drive the growth of the market. Furthermore, growth in healthcare expenditures in the developing economies create a lucrative opportunity for market growth.
Major end users in the market
The report includes the analysis of the major end users in the global urinary incontinence devices market, such as hospitals, clinics, and others. In 2021, the hospitals segment contributed the largest share, accounting for about half of the total revenue, because majority of the pregnant women suffer from urinary incontinence as well as a large patient pool who are admitted in hospitals suffer from chronic conditions. However, the clinics segment is expected to register the fastest CAGR of 11.9% during the forecast period.
Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/4550
Based on end user, the hospitals segment accounted for the highest share in 2020, contributing to around half of the global urinary incontinence device market, and is expected to continue its dominant share in terms of revenue during the forecast period. However, the clinics segment is estimated to witness the fastest CAGR of 12.3% from 2021 to 2030.
Based on region, North America held the highest share in 2020, contributed to more than one-third of the total share, and is projected to continue its lead position by 2030. However, Asia-Pacific is projected to portray the largest CAGR of 13.1% during the forecast period.
Leading players of the global urinary incontinence device market analyzed in the research include
- Becton
- Dickinson and Company (C.R. Bard Inc.)
- Caldera Medical
- Boston Scientific Corporation
- ConvaTec Group plc.
- Coloplast A/S
- Johnson & Johnson (Ethicon Inc.)
- Cook Group Inc. (Cook Medical Inc.)
- Medtronic plc.
- Laborie Medical (Cogentix Medical Inc.)
- Teleflex Incorporated.